MedTrace Logo

Lung Clearance Index and Lung Allograft Dysfunction

NCT03850002 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2019-07-25

No results posted yet for this study

Summary

The aim of this project is to evaluate the ability of the lung clearance index (LCI) to detect early chronic lung allograft failure (CLAD) in adult lung transplant recipients over a period of 3 years.

Conditions

  • Lung Transplantation
  • Chronic Lung Allograft Dysfunction
  • Rejection Lung Transplant

Interventions

OTHER

Early detection of CLAD by Lung Clearance Index (LCI)

Lung transplant candidates without prior CLAD (evaluated in study part I) will be followed over a period of 3 years to evaluate the potential of LCI to detect early CLAD

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Christian Benden, Prof., MD · University Hospital of Zurich, Zurich, Switzerland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2022-12-31
Completion
2023-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03850002 on ClinicalTrials.gov